Sorrento Therapeutics logo
Sorrento Therapeutics SRNE
$ 0.27 -29.58%

Quarterly report 2023-Q1
added 05-15-2023

report update icon

Sorrento Therapeutics Cash and Cash Equivalents 2011-2024 | SRNE

Annual Cash and Cash Equivalents Sorrento Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
36.7 M 56.5 M 22.5 M 159 M 20.4 M 82.4 M 39 M 71.9 M 31.7 M 5.09 M 3.47 M

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
159 M 3.47 M 48 M

Quarterly Cash and Cash Equivalents Sorrento Therapeutics

2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
37.7 M 23.6 M 70.7 M 70.3 M 112 M 36.7 M 39.7 M 77.3 M 41.7 M 56.5 M 56.5 M 56.5 M 56.5 M 22.5 M 22.5 M 22.5 M 22.5 M 159 M 159 M 159 M 159 M 20.4 M 20.4 M 20.4 M 20.4 M 82.4 M 82.4 M 82.4 M 82.4 M 39 M 39 M 39 M 39 M 71.9 M 71.9 M 71.9 M 71.9 M 31.7 M 31.7 M 31.7 M 31.7 M 5.09 M 5.09 M 5.09 M 5.09 M 3.47 M 3.47 M 3.47 M 3.47 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
159 M 3.47 M 50.5 M